Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Mecoli

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|September 4, 2021
Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific AutoantibodiesMaria Casal-Dominguez, Iago Pinal-Fernandez, Katherine Pak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2022
Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General PopulationChristopher A Mecoli, Tak Igusa, Mengkun Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Improved Detection of Myositis-Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison with Line Blot and Conventional ImmunoprecipitationPeter D Burbelo, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Seminars in Arthritis and Rheumatism|November 21, 2022
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working groupDana DiRenzo, Didem Saygin, Ingrid de Groot, et al.
Annals of the Rheumatic Diseases|August 25, 2022
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodiesYuji Hosono, Brandon Sie, Iago Pinal-Fernandez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2020
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19Livia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2025
Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseasesSamuel D Curtis, Tingshan Liu, Yuxin Bai, et al.
Clinical and Experimental Rheumatology|March 4, 2024
Collaborative research in myositis-related disorders: MIHRA, a global shared community modelLesley Ann Saketkoo, Julie J Paik, Helene Alexanderson, et al.
Arthritis Care & Research|March 6, 2026
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome MeasuresDidem Saygin, Matthew Diller, Varsha Surampudi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2021
Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune DiseasesKathryn C Fitzgerald, Christopher A Mecoli, Morgan Douglas, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Arthritis & Rheumatology (Hoboken, N.J.)|September 4, 2021
Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific AutoantibodiesMaria Casal-Dominguez, Iago Pinal-Fernandez, Katherine Pak, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2022
Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General PopulationChristopher A Mecoli, Tak Igusa, Mengkun Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Improved Detection of Myositis-Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison with Line Blot and Conventional ImmunoprecipitationPeter D Burbelo, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Seminars in Arthritis and Rheumatism|November 21, 2022
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working groupDana DiRenzo, Didem Saygin, Ingrid de Groot, et al.
Annals of the Rheumatic Diseases|August 25, 2022
Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodiesYuji Hosono, Brandon Sie, Iago Pinal-Fernandez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2020
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19Livia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2025
Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseasesSamuel D Curtis, Tingshan Liu, Yuxin Bai, et al.
Clinical and Experimental Rheumatology|March 4, 2024
Collaborative research in myositis-related disorders: MIHRA, a global shared community modelLesley Ann Saketkoo, Julie J Paik, Helene Alexanderson, et al.
Arthritis Care & Research|March 6, 2026
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome MeasuresDidem Saygin, Matthew Diller, Varsha Surampudi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2021
Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune DiseasesKathryn C Fitzgerald, Christopher A Mecoli, Morgan Douglas, et al.
Pageof 8